Literature DB >> 26644585

Stepping toward therapeutic CRISPR.

Keith T Gagnon1, David R Corey2.   

Abstract

Mesh：

Year:  2015        PMID： 26644585      PMCID： PMC4697397          DOI： 10.1073/pnas.1521670112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  RNA interference in mammalian cells by chemically-modified RNA.

Authors:  Dwaine A Braasch; Susan Jensen; Yinghui Liu; Kiran Kaur; Khalil Arar; Michael A White; David R Corey
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

Review 2.  Expanding the Biologist's Toolkit with CRISPR-Cas9.

Authors:  Samuel H Sternberg; Jennifer A Doudna
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

Review 3.  Therapeutic face of RNAi: in vivo challenges.

Authors:  Hojat Borna; Saber Imani; Maryam Iman; Sadegh Azimzadeh Jamalkandi
Journal:  Expert Opin Biol Ther       Date:  2014-11-15       Impact factor: 4.388

Review 4.  How specific is CRISPR/Cas9 really?

Authors:  Henriette O'Geen; Abigail S Yu; David J Segal
Journal:  Curr Opin Chem Biol       Date:  2015-10-24       Impact factor: 8.822

Review 5.  Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia.

Authors:  Daniel J Rader; John J P Kastelein
Journal:  Circulation       Date:  2014-03-04       Impact factor: 29.690

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

7.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.

Authors:  Ayal Hendel; Rasmus O Bak; Joseph T Clark; Andrew B Kennedy; Daniel E Ryan; Subhadeep Roy; Israel Steinfeld; Benjamin D Lunstad; Robert J Kaiser; Alec B Wilkens; Rosa Bacchetta; Anya Tsalenko; Douglas Dellinger; Laurakay Bruhn; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2015-06-29       Impact factor: 54.908

Review 8.  Designing chemically modified oligonucleotides for targeted gene silencing.

Authors:  Glen F Deleavey; Masad J Damha
Journal:  Chem Biol       Date:  2012-08-24

9.  Application of CRISPR/Cas9 for biomedical discoveries.

Authors:  Sean M Riordan; Daniel P Heruth; Li Q Zhang; Shui Qing Ye
Journal:  Cell Biosci       Date:  2015-06-21       Impact factor: 7.133

10.  Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

Authors:  Sojung Kim; Daesik Kim; Seung Woo Cho; Jungeun Kim; Jin-Soo Kim
Journal:  Genome Res       Date:  2014-04-02       Impact factor: 9.043
View more
  5 in total

1.  Expression of PTEN-long mediated by CRISPR/Cas9 can repress U87 cell proliferation.

Authors:  Na Fang; Tingxuan Gu; Yahui Wang; Shuzhen Wang; Fengling Wang; Yang An; Wenqiang Wei; Weijuan Zhang; Xiangqian Guo; Adil J Nazarali; Shaoping Ji
Journal:  J Cell Mol Med       Date:  2017-06-19       Impact factor: 5.310

2.  Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.

Authors:  Christopher L Barkau; Daniel O'Reilly; Kushal J Rohilla; Masad J Damha; Keith T Gagnon
Journal:  Nucleic Acid Ther       Date:  2019-04-16       Impact factor: 5.486

3.  Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity.

Authors:  Daniel O'Reilly; Zachary J Kartje; Eman A Ageely; Elise Malek-Adamian; Maryam Habibian; Annabelle Schofield; Christopher L Barkau; Kushal J Rohilla; Lauren B DeRossett; Austin T Weigle; Masad J Damha; Keith T Gagnon
Journal:  Nucleic Acids Res       Date:  2019-01-25       Impact factor: 16.971

4.  Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.

Authors:  Sunit Jana; Leonora Abdullahu; Eman A Ageely; Ramadevi Chilamkurthy; Daniel O'Reilly; Philip J Jensik; Masad J Damha; Keith T Gagnon
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

Review 5.  RNA biology of disease-associated microsatellite repeat expansions.

Authors:  Kushal J Rohilla; Keith T Gagnon
Journal:  Acta Neuropathol Commun       Date:  2017-08-29       Impact factor: 7.801
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.